A story in The Telegraph says British members of parliament are calling for a criminal investigation into DePuy Orthopaedics, a division of Johnson & Johnson that manufactured “metal-on-metal” hip implants.
A Telegraph investigation found that DePuy continued to market the implants, which feature both a ball and socket coated in metal, after a leading British surgeon warned a company executive that they were causing read more.... --> continue reading...
An orthopedic surgeon testifying at a trial over Johnson & Johnson’s ASR hip implants described tissue colored black with metal debris around the hip joint as the “signature injury” of the devices.
According to a story in the Newark Star Ledger, Dr. Craig Swenson of La Jolla, Calif., refers to the blackened tissue around the artificial hip joints as the “black hole.”
The trial in Los Angeles is the first of 10,000 ...
continue reading...Johnson & Johnson’s earnings for the fourth quarter were better than expected, despite $800 million in expenses related to the company’s recall of its all-metal hip implant.
According to a story in Reuters, the company earned $1.19 per share, excluding one-time items, in the fourth quarter. That beat analysts’ average estimate of $1.17.
The story says the company faces about 2,000 lawsuits related to the “metal-on-metal” hip implant manufactured by Johnson & ...
continue reading...A 2011 internal report from Johnson & Johnson concluded that the company’s metal-on-metal hip implants would fail within five years in nearly 40 percent of patients, requiring them to undergo painful and costly replacement procedures.
A story in the New York Times says Johnson & Johnson recalled the device, made by subsidiary DePuy Orthopaedics, in 2010. Yet even as the company ...
continue reading...
Legal documents released in Johnson & Johnson’s trial regarding all-metal hip implants reveal that the company was aware of problems with the devices in 2008 – two years before recalling them, the Wall Street Journal reports.
For example, the company was in possession of clinical data showing “extreme” levels of metal ions in patients who received the devices, compared to patients who received a product from a rival company. The all-metal ...
continue reading...The U.S. Food and Drug Administration has sent a warning letter to medical device manufacturer St. Jude Medical, warning of problems with manufacturing and quality control at the California plant where the company makes implantable heart defibrillators.
A story in the New York Times notes that the St. Paul-based company has been struggling to deal with problems involving wires that are used to attach the defibrillator to the heart. The wires ...
continue reading...
